US pharma boss calls tariffs a 'pivotal moment'
Eli Lilly's CEO has told the BBC that he is doubtful tariffs could bring manufacturing jobs to the US whilst raising billions in tax revenue.
Lilly
since
auto-detected in 362 stories
36 days ago
Eli Lilly boss: 'Tariffs are pivotal moment and hard to come back from'
The Chief Executive of Eli Lilly has told the BBC that he is doubtful tariffs could bring manufacturing jobs to the US whilst raising billions in tax revenue
38 days ago
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
found
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.
42 days ago
EU regulator rejects Lilly’s Alzheimer’s drug
The agency said the benefits do not outweigh the risks.
The CoreWeave IPO is key to 2 portfolio stocks — plus, Lilly bucks a down market
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
EU drugs regulator rejects Lilly’s Alzheimer’s drug
The agency said the benefits do not outweigh the risks.
45 days ago
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes.
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes.
64 days ago
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound
found
Telehealth firms Teladoc and LifeMD said they signed an agreement with Eli Lilly's pharmacy partner to offer patients the weight-loss drug, Zepbound.
71 days ago
Eli Lilly plans $27bn in new plants as Trump threatens pharma tariffs
The new plants will be built in the US over the next five years and create 3,000 jobs for skilled workers.
|← first ← previous page 2 of 4 next → last →|